Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF2AP2 (ENSG00000271568) is a *pseudogene* corresponding to the eukaryotic translation initiation factor 2A, 65kDa. Unlike the functional EIF2A gene, pseudogenes like EIF2AP2 do not encode active proteins. Instead, pseudogenes are generally considered noncoding sequences that have lost their protein-coding potential through evolutionary processes, and therefore do not have defined protein structure, biological function, or therapeutic relevance. No evidence supports a disease role or drug targeting for EIF2AP2. Key Points & Clarifications: - Pseudogene status: The field "is_incorrect" is *true* specifically because this entry describes a pseudogene, not a targetable receptor, enzyme, transporter, or other typical drug target. - There is a functional gene **EIF2A** (eukaryotic translation initiation factor 2A), sometimes referenced similarly; however, **EIF2AP2/ENSG00000271568** refers *specifically to a pseudogene*, not the active protein[7][8]. - Pseudogenes are sometimes studied for their regulatory roles (as noncoding RNAs) but have no direct protein or pathway function[1][2].
None applicable (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EIF2A eukaryotic translation initiation factor 2A, 65kDa, pseudogene (EIF2AP2).